Mesothelin-specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3-treated self-differentiated dendritic cells

Triple negative breast cancer (TNBC) lacks targeted treatment resulting in poor prognosis. Targeting overexpressing mesothelin (MSLN) using MSLN-specific T cells is an attractive treatment approach and the aim of the present study. The expression of MSLN in human TNBC paraffin sections was analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Jirapongwattana, Niphat, Thongchot, Suyanee, Chiraphapphaiboon, Wannasiri, Chieochansin, Thaweesak, Sa-Nguanraksa, Doonyapat, Warnnissorn, Malee, Thuwajit, Peti, Yenchitsomanus, Pa-Thai, Thuwajit, Chanitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164262/
https://www.ncbi.nlm.nih.gov/pubmed/35616135
http://dx.doi.org/10.3892/or.2022.8338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164262/
https://www.ncbi.nlm.nih.gov/pubmed/35616135
http://dx.doi.org/10.3892/or.2022.8338

Ejemplares similares